Emergent BioSolutions, Inc. (NYSE:EBS)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on the development, manufacture and commercialization of immunobiotics. The Company operates in two business segments: biodefense and commercial.

Recs

0
Player Avatar williamscaps (< 20) Submitted: 9/27/2010 12:55:42 PM : Underperform Start Price: $18.80 EBS Score: +38.75

18.78

Featured Broker Partners


Advertisement